| The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy B Humphries, C Yang Oncotarget 6 (9), 6472, 2015 | 359 | 2015 |
| MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis B Humphries, Z Wang, AL Oom, T Fisher, D Tan, Y Cui, Y Jiang, C Yang Carcinogenesis 35 (10), 2254-2263, 2014 | 123 | 2014 |
| MicroRNAs: novel players in cancer diagnosis and therapies AL Oom, BA Humphries, C Yang BioMed research international 2014, 2014 | 98 | 2014 |
| Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway Y Xiao, Y Li, H Tao, B Humphries, A Li, Y Jiang, C Yang, R Luo, Z Wang Cancer letters 433, 199-209, 2018 | 91 | 2018 |
| ARHGAP18 downregulation by miR-200b suppresses metastasis of triple-negative breast cancer by enhancing activation of RhoA B Humphries, Z Wang, Y Li, JR Jhan, Y Jiang, C Yang Cancer Research 77 (15), 4051-4064, 2017 | 76 | 2017 |
| Root-localized phytochrome chromophore synthesis is required for photoregulation of root elongation and impacts root sensitivity to jasmonic acid in Arabidopsis SE Costigan, SN Warnasooriya, BA Humphries, BL Montgomery Plant physiology 157 (3), 1138-1150, 2011 | 75 | 2011 |
| MicroRNA-200b suppresses arsenic-transformed cell migration by targeting protein kinase Cα and Wnt5b-protein kinase Cα positive feedback loop and inhibiting Rac1 activation Z Wang, B Humphries, H Xiao, Y Jiang, C Yang Journal of Biological Chemistry 289 (26), 18373-18386, 2014 | 70 | 2014 |
| Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer BA Humphries, AC Cutter, JM Buschhaus, YC Chen, T Qyli, ... Breast Cancer Research 22, 1-18, 2020 | 65 | 2020 |
| MiR-205 dysregulations in breast cancer: the complexity and opportunities Y Xiao, B Humphries, C Yang, Z Wang Non-coding RNA 5 (4), 53, 2019 | 59 | 2019 |
| MicroRNA regulation of epigenetic modifiers in breast cancer B Humphries, Z Wang, C Yang Cancers 11 (7), 897, 2019 | 59 | 2019 |
| Upregulation of histone-lysine methyltransferases plays a causal role in hexavalent chromium-induced cancer stem cell-like property and cell transformation Z Wang, J Wu, B Humphries, K Kondo, Y Jiang, X Shi, C Yang Toxicology and applied pharmacology 342, 22-30, 2018 | 56 | 2018 |
| Plasminogen activator inhibitor 1 (PAI1) promotes actin cytoskeleton reorganization and glycolytic metabolism in triple-negative breast cancer BA Humphries, JM Buschhaus, YC Chen, HR Haley, T Qyli, B Chiang, ... Molecular Cancer Research 17 (5), 1142-1154, 2019 | 55 | 2019 |
| Single-cell RNA-sequencing of migratory breast cancer cells: discovering genes associated with cancer metastasis YC Chen, S Sahoo, R Brien, S Jung, B Humphries, W Lee, YH Cheng, ... Analyst 144 (24), 7296-7309, 2019 | 54 | 2019 |
| The role of microRNAs in metal carcinogen-induced cell malignant transformation and tumorigenesis B Humphries, Z Wang, C Yang Food and Chemical Toxicology 98, 58-65, 2016 | 54 | 2016 |
| Rho GTPases: big players in breast cancer initiation, metastasis and therapeutic responses B Humphries, Z Wang, C Yang Cells 9 (10), 2167, 2020 | 48 | 2020 |
| Integrin α9 depletion promotes β‐catenin degradation to suppress triple‐negative breast cancer tumor growth and metastasis Z Wang, Y Li, Y Xiao, HP Lin, P Yang, B Humphries, T Gao, C Yang International journal of cancer 145 (10), 2767-2780, 2019 | 47 | 2019 |
| Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin–vascular endothelial growth factor pathway Z Wang, B Humphries, H Xiao, Y Jiang, C Yang Toxicology and applied pharmacology 271 (1), 20-29, 2013 | 46 | 2013 |
| Morphology-based prediction of cancer cell migration using an artificial neural network and a random decision forest Z Zhang, L Chen, B Humphries, R Brien, MS Wicha, KE Luker, GD Luker, ... Integrative biology 10 (12), 758-767, 2018 | 40 | 2018 |
| Functional isolation of tumor-initiating cells using microfluidic-based migration identifies phosphatidylserine decarboxylase as a key regulator YC Chen, B Humphries, R Brien, AE Gibbons, YT Chen, T Qyli, HR Haley, ... Scientific reports 8 (1), 244, 2018 | 37 | 2018 |
| Nanoparticle-mediated therapeutic agent delivery for treating metastatic breast cancer—challenges and opportunities Y Li, B Humphries, C Yang, Z Wang Nanomaterials 8 (6), 361, 2018 | 33 | 2018 |
